| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVE BLDG 83-1D | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43AI152650 | Low-cost Production of a Vaccine for Lyme Disease in Maize | 000 | 2 | NIH | 8/28/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $310,667 ) |
| | 2022 | 2022 | APPLIED BIOTECHNOLOGY INSTITUTE, INC. | 1 GRAND AVE BLDG 83-1D CAL POLY TECHNOLOGY PK | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R43AI152650 | Low-cost Production of a Vaccine for Lyme Disease in Maize | 000 | 2 | NIH | 2/23/2022 | $310,667 |
|
| Issue Date FY: 2021 ( Subtotal = $282,857 ) |
| | 2021 | 2021 | APPLIED BIOTECHNOLOGY INSTITUTE, INC. | 1 GRAND AVE BLDG 83-1D CAL POLY TECHNOLOGY PK | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R43AI152650 | Low-cost Production of a Vaccine for Lyme Disease in Maize | 000 | 1 | NIH | 3/2/2021 | $282,857 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | APPLIED BIOTECHNOLOGY INSTITUTE, INC. | 1 GRAND AVE BLDG 83-1D | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43AI134104 | Production of stabilized trimeric HIV Env protein in maize | 000 | 1 | NIH | 5/14/2019 | $0 |
| | 2019 | 2016 | Applied Biotechnology Institute, Inc. | 1 Grand Ave Bldg 83-1d | San Luis Obispo | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43CK000493 | Production of immunogenic Ebola GP protein in maize | 05 | 1 | CDC | 9/30/2019 | $0 |
| | 2019 | 2016 | Applied Biotechnology Institute, Inc. | 1 Grand Ave Bldg 83-1d | San Luis Obispo | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43CK000493 | Production of immunogenic Ebola GP protein in maize | 05 | 1 | CDC | 9/30/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | APPLIED BIOTECHNOLOGY INSTITUTE, INC. | CALPOLY TECHNOLOGY PARK BUILDING 83 | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R43CK000493 | Production of immunogenic Ebola GP protein in maize | 000 | 1 | CDC | 11/16/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $149,928 ) |
| | 2017 | 2017 | APPLIED BIOTECHNOLOGY INSTITUTE, INC. | CALPOLY TECHNOLOGY PARK BUILDING 83 | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R43AI134104 | Production of stabilized trimeric HIV Env protein in maize | 000 | 1 | NIH | 5/22/2017 | $149,928 |
| | 2017 | 2016 | APPLIED BIOTECHNOLOGY INSTITUTE, INC. | CALPOLY TECHNOLOGY PARK BUILDING 83 | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R43CK000493 | Production of immunogenic Ebola GP protein in maize | 000 | 1 | CDC | 11/16/2016 | $0 |
| | 2017 | 2016 | APPLIED BIOTECHNOLOGY INSTITUTE, INC. | CALPOLY TECHNOLOGY PARK BUILDING 83 | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R43DK109746 | Improving the efficacy of hepatitis B prophylactic vaccines | 000 | 1 | NIH | 7/20/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $294,051 ) |
| | 2016 | 2016 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43CK000493 | Production of immunogenic Ebola GP protein in maize | 002 | 1 | CDC | 9/9/2016 | $147,275 |
| | 2016 | 2016 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43CK000493 | Production of immunogenic Ebola GP protein in maize | 001 | 1 | CDC | 9/7/2016 | -$147,275 |
| | 2016 | 2016 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43DK109746 | Improving the efficacy of hepatitis B prophylactic vaccines | 000 | 1 | NIH | 4/11/2016 | $146,776 |
| | 2016 | 2016 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43CK000493 | Production of immunogenic Ebola GP protein in maize | 000 | 1 | CDC | 8/26/2016 | $147,275 |
|
| Issue Date FY: 2014 ( Subtotal = $727,729 ) |
| | 2014 | 2014 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R44AI068239 | An Orally Delivered Booster Vaccine Candidate for Hepatitis B | 000 | 5 | NIH | 4/10/2014 | $727,729 |
|
| Issue Date FY: 2013 ( Subtotal = $911,830 ) |
| | 2013 | 2013 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R44AI068239 | An Orally Delivered Booster Vaccine Candidate for Hepatitis B | 000 | 4 | NIH | 4/12/2013 | $911,830 |
|
| Issue Date FY: 2012 ( Subtotal = $943,211 ) |
| | 2012 | 2012 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R44AI068239 | An Orally Delivered Booster Vaccine Candidate for Hepatitis B | 001 | 3 | NIH | 8/8/2012 | -$943,211 |
| | 2012 | 2012 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R44AI068239 | An Orally Delivered Booster Vaccine Candidate for Hepatitis B | 000 | 3 | NIH | 4/26/2012 | $943,211 |
| | 2012 | 2012 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R44AI068239 | An Orally Delivered Booster Vaccine Candidate for Hepatitis B | 001 | 3 | NIH | 8/8/2012 | $943,211 |
|
| Issue Date FY: 2009 ( Subtotal = $321,842 ) |
| | 2009 | 2009 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43AI068239 | AN ORALLY DELIVERED HEPATITIS B VACCINE | 001 | 2 | NIH | 6/23/2009 | $295,299 |
| | 2009 | 2009 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407-9000 | SAN LUIS OBISPO | USA | R43AI068239 | AN ORALLY DELIVERED HEPATITIS B VACCINE | 000 | 1 | NIH | 6/3/2009 | $26,543 |
|
| Issue Date FY: 2008 ( Subtotal = $295,171 ) |
| | 2008 | 2008 | APPLIED BIOTECHNOLOGY INSTITUTE INC | 1 GRAND AVENUE | SAN LUIS OBISPO | CA | 93407 | SAN LUIS OBISPO | USA | R43AI068239 | AN ORALLY DELIVERED HEPATITIS B VACCINE | 000 | 1 | NIH | 6/23/2008 | $295,171 |
|
|
